Interaction of spirochetes with the host fibrinolytic system and potential roles in pathogenesis

Critical Reviews in Microbiology

Volumn 42, Issue 4, 2016, Pages 573-587

  Vieira, Mônica Larucci ^a   Nascimento, Ana Lucia T O ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Borrelia; fibrinolytic system; Leptospira; plasminogen plasmin; treponema

Indexed keywords

FIBRIN; GLYCOPROTEIN; METALLOPROTEINASE; PLASMIN; PLASMINOGEN; MATRIX METALLOPROTEINASE; PROTEIN BINDING;

BIFIDOBACTERIUM ANIMALIS; BORRELIA BURGDORFERI; CELL MIGRATION; EXTRACELLULAR MATRIX; FIBRINOLYSIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNE SYSTEM; IN VITRO STUDY; LEPTOSPIRA; LEPTOSPIROSIS; MOLECULAR INTERACTION; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEOMICS; PSEUDOMONAS AERUGINOSA; REVIEW; SCHISTOSOMA BOVIS; SIGNAL TRANSDUCTION; SPECIES INVASION; SPIROCHETE; SPIROCHETE INFECTION; STREPTOCOCCUS PNEUMONIAE; SURFACE PROPERTY; TREPONEMA DENTICOLA; BORRELIA; METABOLISM; PATHOGENICITY;

BORRELIA; FIBRINOLYSIN; FIBRINOLYSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; LEPTOSPIRA; MATRIX METALLOPROTEINASES; PLASMINOGEN; PROTEIN BINDING; PROTEOLYSIS; TREPONEMA DENTICOLA;

EID: 84977654240     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2014.972336     Document Type: Review

References (212)

1. C.Attali, C.Durmort, T.Vernet, A.M.Di Guilmi. (2008). The interaction of Streptococcus pneumoniae with plasmin mediates transmigration across endothelial and epithelial monolayers by intercellular junction cleavage. Infect Immun 76:5350–6
2. M.V.Atzingen, G.M.Cerqueira, M.L.Vieira,. (2010). Identification and characterization of novel adhesins in leptospira. In: A.M.Vilas, ed. Current research, technology and education topics in applied microbiology and microbial biotechnology. Badajoz, Spain: Formatex Research Center, 704--13
3. E.Banfi, M.Cinco, M.Bellini, M.R.Soranzo. (1982). The role of antibodies and serum complement in the interaction between macrophages and leptospires. J Gen Microbiol 128:813–16
4. A.S.Barbosa, P.A.Abreu, F.O.Neves,. (2006). A newly identified leptospiral adhesin mediates attachment to laminin. Infect Immun 74:6356–64
5. A.S.Barbosa, P.A.Abreu, S.A.Vasconcellos,. (2009). Immune evasion of leptospira species by acquisition of human complement regulator C4BP. Infect Immun 77:1137–43
6. A.G.Barbour, B.P.Guo. (2009). Pathogenesis of relapsing fever. In: S.Samuels, J.Radolf, eds. Borrelia: molecular and cellular biology. Norwich, U.K: Horizon Scientific Press, 333--57
7. A.G.Barbour, A.D.Putteet-Driver, J.Bunikis. (2005). Horizontally acquired genes for purine salvage in Borrelia spp. causing relapsing fever. Infect Immun 73:6165–8
8. M.A.Barocchi, A.I.Ko, M.G.Reis,. (2002). Rapid translocation of polarized MDCK cell monolayers by Leptospira interrogans, an invasive but nonintracellular pathogen. Infect Immun 70:6926–32
9. D.Barthel, B.Singh, K.Riesbeck, P.F.Zipfel. (2012). Haemophilus influenzae uses the surface protein E to acquire human plasminogen and to evade innate immunity. J Immunol 188:379–85
10. A.K.Behera, C.M.Thorpe, J.M.Kidder,. (2004). Borrelia burgdorferi-induced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and Janus kinase/signal transducer and activator of transcription signaling pathways. Infect Immun 72:2864–71
11. S.Bergmann, S.Hammerschmidt. (2007). Fibrinolysis and host response in bacterial infections. Thromb Haemost 98:512–20
12. S.Bergmann, H.Schoenen, S.Hammerschmidt. (2013). The interaction between bacterial enolase and plasminogen promotes adherence of Streptococcus pneumoniae to epithelial and endothelial cells. Int J Med Microbiol 303:452–62
13. A.R.Bharti, J.E.Nally, J.N.Ricaldi,. (2003). Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3:757–71
14. S.Bhattacharya, V.A.Ploplis, F.J.Castellino. (2012). Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination. J Biomed Biotechnol 2012:482096
15. A.M.Blom, T.Hallstrom, K.Riesbeck. (2009). Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol Immunol 46:2808–17
16. J.Boncela, P.Przygodzka, I.Papiewska-Pajak,. (2011). Plasminogen activator inhibitor type 1 interacts with alpha3 subunit of proteasome and modulates its activity. J Biol Chem 286:6820–31
17. R.Brauer, I.M.Beck, M.Roderfeld,. (2011). Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen. BMC Biochem 12:38
18. C.A.Brissette, K.Haupt, D.Barthel,. (2009). Borrelia burgdorferi infection-associated surface proteins ErpP, ErpA, and ErpC bind human plasminogen. Infect Immun 77:300–6
19. C.S.Brooks, S.R.Vuppala, A.M.Jett,. (2005). Complement regulator-acquiring surface protein 1 imparts resistance to human serum in Borrelia burgdorferi. J Immunol 175:3299–308
20. T.Bykowski, M.E.Woodman, A.E.Cooley,. (2007). Coordinated expression of Borrelia burgdorferi complement regulator-acquiring surface proteins during the Lyme disease spirochete's mammal-tick infection cycle. Infect Immun 75:4227–36
21. M.Candela, E.Biagi, M.Centanni,. (2009). Bifidobacterial enolase, a cell surface receptor for human plasminogen involved in the interaction with the host. Microbiology 155:3294–303
22. S.Chaemchuen, S.Rungpragayphan, Y.Poovorawan, K.Patarakul. (2011). Identification of candidate host proteins that interact with LipL32, the major outer membrane protein of pathogenic Leptospira, by random phage display peptide library. Vet Microbiol 153:178–85
23. W.Chierakul, P.Tientadakul, Y.Suputtamongkol,. (2008). Activation of the coagulation cascade in patients with leptospirosis. Clin Infect Dis 46:254–60
24. B.K.Choi, H.J.Lee, J.H.Kang,. (2003). Induction of osteoclastogenesis and matrix metalloproteinase expression by the lipooligosaccharide of Treponema denticola. Infect Immun 71:226–33
25. M.C.Chung, J.H.Tonry, A.Narayanan,. (2011). Bacillus anthracis interacts with plasmin(ogen) to evade C3b-dependent innate immunity. PLoS One 6:e18119
26. M.Cinco. (2010). New insights into the pathogenicity of leptospires: evasion of host defences. New Microbiol 33:283–92
27. M.Cinco, E.Banfi. (1983). Activation of complement by leptospires and its bactericidal activity. Zentralbl Bakteriol Mikrobiol Hyg A 254:261–5
28. M.Cinco, E.Banfi, M.R.Soranzo. (1981). Studies on the interaction between macrophages and leptospires. J Gen Microbiol 124:409–13
29. M.Cinco, E.Banfi, M.R.Soranzo. (1982). Leptospires macrophage interactions. Adv Exp Med Biol 141:167–74
30. J.L.Coleman, J.L.Benach. (2000). The generation of enzymatically active plasmin on the surface of spirochetes. Methods 21:133–41
31. J.L.Coleman, J.A.Gebbia, J.Piesman,. (1997). Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 89:1111–19
32. J.L.Coleman, T.J.Sellati, J.E.Testa,. (1995). Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers. Infect Immun 63:2478–84
33. D.Collen, H.R.Lijnen. (2005). Thrombolytic agents. Thromb Haemost 93:627–30
34. R.W.Colman, R.B.Sartor, A.A.Adam,. (1998). The plasma kallikrein-kinin system in sepsis, inflammatory arthritis, and enterocolitis. Clin Rev Allergy Immunol 16:365–84
35. L.E.Comstock, D.D.Thomas. (1989). Penetration of endothelial cell monolayers by Borrelia burgdorferi. Infect Immun 57:1626–8
36. S.J.Cutler, A.Abdissa, J.F.Trape. (2009). New concepts for the old challenge of African relapsing fever borreliosis. Clin Microbiol Infect 15:400–6
37. E.De Francesco Daher, F.H.Oliveira Neto, S.M.Ramirez. (2002). Evaluation of hemostasis disorders and anticardiolipin antibody in patients with severe leptospirosis. Rev Inst Med Trop Sao Paulo 44:85–90
38. E.De La Torre-Escudero, R.Manzano-Roman, R.Perez-Sanchez,. (2010). Cloning and characterization of a plasminogen-binding surface-associated enolase from Schistosoma bovis. Vet Parasitol 173:76–84
39. A.M.De Silva, S.R.TelfordIII, L.R.Brunet,. (1996). Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med 183:271–5
40. J.L.Degen, T.H.Bugge, J.D.Goguen. (2007). Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost 5:24–31
41. R.F.Domingos, M.L.Vieira, E.C.Romero,. (2012). Features of two proteins of Leptospira interrogans with potential role in host-pathogen interactions. BMC Microbiol 12:50
42. B.A.Dye, S.Tan, V.Smith,. (2007). Trends in oral health status: United States, 1988–1994 and 1999–2004. Vital Health Stat 11:1–92
43. A.M.Edwards, H.F.Jenkinson, M.J.Woodward, D.Dymock. (2005). Binding properties and adhesion-mediating regions of the major sheath protein of Treponema denticola ATCC 35405. Infect Immun 73:2891–8
44. C.N.Edwards, G.D.Nicholson, T.A.Hassell,. (1986). Thrombocytopenia in leptospirosis: the absence of evidence for disseminated intravascular coagulation. Am J Trop Med Hyg 35:352–4
45. B.M.Eley, S.W.Cox. (1992). Correlation of gingival crevicular fluid proteases with clinical and radiological measurements of periodontal attachment loss. J Dent 20:90–9
46. A.Estreicher, J.Muhlhauser, J.L.Carpentier,. (1990). The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol 111:783–92
47. S.Faine, B.Adler, C.Bolin, P.Perolat. (1999). Leptospira and leptospirosis, 2nd ed. Melbourne, Australia: MediSci
48. J.C.Fenno, K.H.Muller, B.C.Mcbride. (1996). Sequence analysis, expression, and binding activity of recombinant major outer sheath protein (Msp) of Treponema denticola. J Bacteriol 178:2489–97
49. J.C.Fenno, M.Tamura, P.M.Hannam,. (2000). Identification of a Treponema denticola OppA homologue that binds host proteins present in the subgingival environment. Infect Immun 68:1884–92
50. L.G.Fernandes, M.L.Vieira, I.J.Alves,. (2014). Functional and immunological evaluation of two novel proteins of Leptospira spp. Microbiology 160:149–64
51. L.G.Fernandes, M.L.Vieira, K.Kirchgatter,. (2012). OmpL1 is an extracellular matrix- and plasminogen-interacting protein of Leptospira spp. Infect Immun 80:3679–92
52. L.M.Fine, D.P.Miller, K.L.Mallory,. (2014). The Borrelia hermsii factor H binding protein FhbA is not required for infectivity in mice or for resistance to human complement in vitro. Infect Immun 82:3324–32
53. A.M.Floden, J.A.Watt, C.A.Brissette. (2011). Borrelia burgdorferi enolase is a surface-exposed plasminogen binding protein. PLoS One 6:e27502
54. T.J.Foster. (2005). Immune evasion by staphylococci. Nat Rev Microbiol 3:948–58
55. H.Fuchs, M.M.Simon, R.Wallich,. (1996). Borrelia burgdorferi induces secretion of pro-urokinase-type plasminogen activator by human monocytes. Infect Immun 64:4307–12
56. H.Fuchs, R.Wallich, M.M.Simon, M.D.Kramer. (1994). The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor. Proc Natl Acad Sci U S A 91:12594–8
57. P.Gaibani, F.Caroli, C.Nucci, V.Sambri. (2010). Major surface protein complex of Treponema denticola induces the production of tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and matrix metalloproteinase 9 by primary human peripheral blood monocytes. J Periodontal Res 45:361–6
58. J.C.Garcia-Monco, J.L.Benach. (1995). Lyme neuroborreliosis. Ann Neurol 37:691–702
59. J.A.Gebbia, P.B.Backenson, J.L.Coleman,. (1997). Glycolytic enzyme operon of Borrelia burgdorferi: characterization and evolutionary implications. Gene 188:221–8
60. J.A.Gebbia, J.L.Coleman, J.L.Benach. (2001). Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cells. Infect Immun 69:456–62
61. J.A.Gebbia, J.L.Coleman, J.L.Benach. (2004). Selective induction of matrix metalloproteinases by Borrelia burgdorferi via toll-like receptor 2 in monocytes. J Infect Dis 189:113–19
62. J.A.Gebbia, J.C.Monco, J.L.Degen,. (1999). The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis. J Clin Invest 103:81–7
63. K.Gijbels, P.Proost, S.Masure,. (1993). Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res 36:432–40
64. D.J.Grab, G.Perides, J.S.Dumler,. (2005). Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier. Infect Immun 73:1014–22
65. D.Grenier. (1996). Degradation of host protease inhibitors and activation of plasminogen by proteolytic enzymes from Porphyromonas gingivalis and Treponema denticola. Microbiology 142:955–61
66. D.Grenier, V.J.Uitto, B.C.Mcbride. (1990). Cellular location of a Treponema denticola chymotrypsinlike protease and importance of the protease in migration through the basement membrane. Infect Immun 58:347–51
67. D.Grimm, K.Tilly, R.Byram,. (2004). Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci USA 101:3142–7
68. S.Grosskinsky, M.Schott, C.Brenner,. (2009). Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity. PLoS One 4:e4858
69. S.Grosskinsky, M.Schott, C.Brenner,. (2010). Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis. PLoS Negl Trop Dis 4:e698
70. E.S.Guner, M.Watanabe, N.Hashimoto,. (2004). Borrelia turcica sp. nov., isolated from the hard tick Hyalomma aegyptium in Turkey. Int J Syst Evol Microbiol 54:1649–52
71. D.A.Haake, M.Dundoo, R.Cader,. (2002). Leptospirosis, water sports, and chemoprophylaxis. Clin Infect Dis 34:e40–3
72. M.Haapasalo, K.H.Muller, V.J.Uitto,. (1992). Characterization, cloning, and binding properties of the major 53-kilodalton Treponema denticola surface antigen. Infect Immun 60:2058–65
73. W.B.Haile, J.L.Coleman, J.L.Benach. (2006). Reciprocal upregulation of urokinase plasminogen activator and its inhibitor, PAI-2, by Borrelia burgdorferi affects bacterial penetration and host-inflammatory response. Cell Microbiol 8:1349–60
74. T.Hallstrom, K.Haupt, P.Kraiczy,. (2010). Complement regulator-acquiring surface protein 1 of Borrelia burgdorferi binds to human bone morphogenic protein 2, several extracellular matrix proteins, and plasminogen. J Infect Dis 202:490–8
75. C.Hammerschmidt, A.Koenigs, C.Siegel,. (2014). Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes. Infect Immun 82:380–92
76. P.C.Harpel, R.Sullivan, T.S.Chang. (1989). Binding and activation of plasminogen on immobilized immunoglobulin G. Identification of the plasmin-derived Fab as the plasminogen-binding fragment. J Biol Chem 264:616–24
77. R.A.Hartskeerl, M.Collares-Pereira, W.A.Ellis. (2011). Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect 17:494–501
78. P.Hauk, A.S.Barbosa, P.L.Ho, C.S.Farah. (2012). Calcium binding to leptospira outer membrane antigen LipL32 is not necessary for its interaction with plasma fibronectin, collagen type IV, and plasminogen. J Biol Chem 287:4826–34
79. P.Hauk, F.Macedo, E.C.Romero,. (2008). In LipL32, the major leptospiral lipoprotein, the C terminus is the primary immunogenic domain and mediates interaction with collagen IV and plasma fibronectin. Infect Immun 76:2642–50
80. H.Herwald, M.Morgelin, A.Olsen,. (1998). Activation of the contact-phase system on bacterial surfaces–a clue to serious complications in infectious diseases. Nat Med 4:298–302
81. P.Herzberger, C.Siegel, C.Skerka,. (2007). Human pathogenic Borrelia spielmanii sp. nov. resists complement-mediated killing by direct binding of immune regulators factor H and factor H-like protein 1. Infect Immun 75:4817–25
82. D.E.Hoke, S.Egan, P.A.Cullen, B.Adler. (2008). LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata. Infect Immun 76:2063–9
83. S.C.Holt, J.L.Ebersole. (2005). Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the “red complex”, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000 38:72–122
84. K.M.Hovis, J.C.Freedman, H.Zhang,. (2008). Identification of an antiparallel coiled-coil/loop domain required for ligand binding by the Borrelia hermsii FhbA protein: additional evidence for the role of FhbA in the host-pathogen interaction. Infect Immun 76:2113–22
85. K.M.Hovis, J.V.Mcdowell, L.Griffin, R.T.Marconi. (2004). Identification and characterization of a linear-plasmid-encoded factor H-binding protein (FhbA) of the relapsing fever spirochete Borrelia hermsii. J Bacteriol 186:2612–18
86. L.T.Hu, M.A.Eskildsen, C.Masgala,. (2001). Host metalloproteinases in Lyme arthritis. Arthritis Rheum 44:1401–10
87. L.T.Hu, G.Perides, R.Noring, M.S.Klempner. (1995). Binding of human plasminogen to Borrelia burgdorferi. Infect Immun 63:3491–6
88. L.T.Hu, S.D.Pratt, G.Perides,. (1997). Isolation, cloning, and expression of a 70-kilodalton plasminogen binding protein of Borrelia burgdorferi. Infect Immun 65:4989–95
89. W.D.Johnson, L.M.Golightly. (2000). Borrelia species (Relapsing fever). In: G.L.Mandell, J.E.Bennett, R.Dolin, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia (PA): Churchill Livingston, 2502--2504
90. A.Kirchner, U.Koedel, V.Fingerle,. (2000). Upregulation of matrix metalloproteinase-9 in the cerebrospinal fluid of patients with acute Lyme neuroborreliosis. J Neurol Neurosurg Psychiatr 68:368–71
91. M.S.Klempner, R.Noring, M.P.Epstein,. (1995). Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis 171:1258–65
92. M.S.Klempner, R.Noring, M.P.Epstein,. (1996). Binding of human urokinase type plasminogen activator and plasminogen to Borrelia species. J Infect Dis 174:97–104
93. A.Koenigs, C.Hammerschmidt, B.L.Jutras,. (2013). BBA70 of Borrelia burgdorferi is a novel plasminogen-binding protein. J Biol Chem 288:25229–43
94. P.Kraiczy, J.Hellwage, C.Skerka,. (2004). Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J Biol Chem 279:2421–9
95. A.Kunert, J.Losse, C.Gruszin,. (2007). Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J Immunol 179:2979–88
96. K.Lahteenmaki, S.Edelman, T.K.Korhonen. (2005). Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol 13:79–85
97. K.Lahteenmaki, P.Kuusela, T.K.Korhonen. (2001). Bacterial plasminogen activators and receptors. FEMS Microbiol Rev 25:531–52
98. J.D.Lambris, D.Ricklin, B.V.Geisbrecht. (2008). Complement evasion by human pathogens. Nat Rev Microbiol 6:132–42
99. A.Y.Lee, J.C.Fredenburgh, R.J.Stewart,. (2001). Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin. Thromb Haemost 85:502–8
100. P.N.Levett. (2001). Leptospirosis. Clin Microbiol Rev 14:296–326
101. S.P.Leytus, L.K.Bowles, J.Konisky, W.F.Mangel. (1981). Activation of plasminogen to plasmin by a protease associated with the outer membrane of Escherichia coli. Proc Natl Acad Sci U S A 78:1485–9
102. Z.Li, V.A.Ploplis, E.L.French, M.D.Boyle. (1999). Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model. J Infect Dis 179:907–14
103. H.R.Lijnen. (2001). Elements of the fibrinolytic system. Ann N Y Acad Sci 936:226–36
104. H.R.Lijnen. (2002). Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mosc) 67:92–8
105. H.R.Lijnen, F.De Cock, B.Van Hoef,. (1994). Characterization of the interaction between plasminogen and staphylokinase. Eur J Biochem 224:143–9
106. H.R.Lijnen, F.Ugwu, A.Bini, D.Collen. (1998). Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry 37:4699–702
107. B.Lin, J.M.Kidder, R.Noring,. (2001). Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment. J Infect Dis 184:174–80
108. Z.Lin, L.Jiang, C.Yuan,. (2011). Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1. J Biol Chem 286:7027–32
109. E.Lindgren, T.G.Jaenson. (2006). Lyme borreliosis in Europe: influences of climate and climate change, epidemiology, ecology and adaptation measures. Copenhagen, Denmark: World Health Organization
110. S.Lobov, D.R.Croucher, D.N.Saunders, M.Ranson. (2008). Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions. Thromb Haemost 100:319–29
111. W.J.Loesche, N.S.Grossman. (2001). Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment. Clin Microbiol Rev 14:727–52, table of contents
112. R.Lottenberg, C.C.Broder, M.D.Boyle,. (1992). Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J Bacteriol 174:5204–10
113. C.M.Marchal, B.J.Luft, X.Yang,. (2009). Defensin is suppressed by tick salivary gland extract during the in vitro interaction of resident skin cells with Borrelia burgdorferi. J Invest Dermatol 129:2515–17
114. G.Margos, S.A.Vollmer, M.Cornet,. (2009). A new Borrelia species defined by multilocus sequence analysis of housekeeping genes. Appl Environ Microbiol 75:5410–16
115. H.E.Mccoy, C.C.Broder, R.Lottenberg. (1991). Streptokinases produced by pathogenic group C streptococci demonstrate species-specific plasminogen activation. J Infect Dis 164:515–21
116. P.S.Mead. (2014). Infectious diseases related to travel: lyme disease. CDC health information for international travel. New York, USA: Oxford University Press
117. R.S.Mendes, M.Von Atzingen, Z.M.De Morais,. (2011). The novel leptospiral surface adhesin Lsa20 binds laminin and human plasminogen and is probably expressed during infection. Infect Immun 79:4657–67
118. T.Meri, R.Murgia, P.Stefanel,. (2005). Regulation of complement activation at the C3-level by serum resistant leptospires. Microb Pathog 39:139–47
119. F.Merien, G.Baranton, P.Perolat. (1997). Invasion of Vero cells and induction of apoptosis in macrophages by pathogenic Leptospira interrogans are correlated with virulence. Infect Immun 65:729–38
120. D.Miao, J.C.Fenno, J.C.Timm,. (2011). The Treponema denticola chymotrypsin-like protease dentilisin induces matrix metalloproteinase-2-dependent fibronectin fragmentation in periodontal ligament cells. Infect Immun 79:806–11
121. D.Miao, V.Godovikova, X.Qian,. (2014). Treponema denticola upregulates MMP-2 activation in periodontal ligament cells: interplay between epigenetics and periodontal infection. Arch Oral Biol 59:1056–64
122. L.A.Miles, S.B.Hawley, N.Baik,. (2005). Plasminogen receptors: the sine qua non of cell surface plasminogen activation. Front Biosci 10:1754–62
123. J.C.Miller, K.Narayan, B.Stevenson, A.R.Pachner. (2005). Expression of Borrelia burgdorferi erp genes during infection of non-human primates. Microb Pathog 39:27–33
124. J.C.Miller, K.Von Lackum, K.Babb,. (2003). Temporal analysis of Borrelia burgdorferi Erp protein expression throughout the mammal-tick infectious cycle. Infect Immun 71:6943–52
125. G.L.Murray, A.Srikram, D.E.Hoke,. (2009). Major surface protein LipL32 is not required for either acute or chronic infection with Leptospira interrogans. Infect Immun 77:952–8
126. A.L.Nascimento, S.Verjovski-Almeida, M.A.Van Sluys,. (2004). Genome features of Leptospira interrogans serovar Copenhageni. Braz J Med Biol Res 37:459–77
127. F.O.Neves, P.A.Abreu, S.A.Vasconcellos,. (2007). Identification of a novel potential antigen for early-phase serodiagnosis of leptospirosis. Arch Microbiol 188:523–32
128. J.J.Nocton, B.J.Bloom, B.J.Rutledge,. (1996). Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 174:623–7
129. J.J.Nocton, F.Dressler, B.J.Rutledge,. (1994). Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 330:229–34
130. S.V.Nogueira, B.T.Backstedt, A.A.Smith,. (2013). Leptospira interrogans enolase is secreted extracellularly and interacts with plasminogen. PLoS One 8:e78150
131. S.V.Nogueira, F.L.Fonseca, M.L.Rodrigues,. (2010). Paracoccidioides brasiliensis enolase is a surface protein that binds plasminogen and mediates interaction of yeast forms with host cells. Infect Immun 78:4040–50
132. S.V.Nogueira, A.A.Smith, J.H.Qin, U.Pal. (2012). A surface enolase participates in Borrelia burgdorferi-plasminogen interaction and contributes to pathogen survival within feeding ticks. Infect Immun 80:82–90
133. A.Nordstrand, A.Shamaei-Tousi, A.Ny, S.Bergstrom. (2001). Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogen-deficient mice. Infect Immun 69:5832–9
134. M.S.O'Reilly, L.Holmgren, Y.Shing,. (1994). Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harb Symp Quant Biol 59:471–82
135. K.Okada, H.R.Lijnen, H.Moreau,. (1996). Procoagulant properties of intravenous staphylokinase versus tissue-type plasminogen activator. Thromb Haemost 76:857–9
136. R.Oliveira, Z.M.De Morais, A.P.Goncales,. (2011). Characterization of novel OmpA-like protein of Leptospira interrogans that binds extracellular matrix molecules and plasminogen. PLoS One 6:e21962
137. R.Oliveira, R.F.Domingos, G.H.Siqueira,. (2013). Adhesins of Leptospira interrogans mediate the interaction to fibrinogen and inhibit fibrin clot formation in vitro. PLoS Negl Trop Dis 7:e2396
138. O.Onder, P.T.Humphrey, B.Mcomber,. (2012). OspC is potent plasminogen receptor on surface of Borrelia burgdorferi. J Biol Chem 287:16860–8
139. A.R.Pachner, E.Delaney. (1993). The polymerase chain reaction in the diagnosis of Lyme neuroborreliosis. Ann Neurol 34:544–50
140. U.Pal, A.M.De Silva, R.R.Montgomery,. (2000). Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J Clin Invest 106:561–9
141. U.Pal, R.R.Montgomery, D.Lusitani,. (2001). Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody. J Immunol 166:7398–403
142. U.Pal, X.Yang, M.Chen,. (2004). OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest 113:220–30
143. B.J.Paster, S.K.Boches, J.L.Galvin,. (2001). Bacterial diversity in human subgingival plaque. J Bacteriol 183:3770–83
144. B.J.Paster, I.Olsen, J.A.Aas, F.E.Dewhirst. (2006). The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontol 2000 42:80–7
145. B.C.Patterson, Q.A.Sang. (1997). Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272:28823–5
146. M.Pausa, V.Pellis, M.Cinco,. (2003). Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. J Immunol 170:3214–22
147. G.Perides, M.E.Charness, L.M.Tanner,. (1998). Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. J Infect Dis 177:401–8
148. G.Perides, L.M.Tanner-Brown, M.A.Eskildsen, M.S.Klempner. (1999). Borrelia burgdorferi induces matrix metalloproteinases by neural cultures. J Neurosci Res 58:779–90
149. J.Pietikainen, T.Meri, A.M.Blom, S.Meri. (2010). Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae. Mol Immunol 47:1299–305
150. M.Pinne, J.Matsunaga, D.A.Haake. (2012). Leptospiral outer membrane protein microarray, a novel approach to identification of host ligand-binding proteins. J Bacteriol 194:6074–87
151. J.Pizarro-Cerda, P.Cossart. (2006). Subversion of cellular functions by Listeria monocytogenes. J Pathol 208:215–23
152. R.Plank, D.Dean. (2000). Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans. Microbes Infect 2:1265–76
153. A.Pozzi, P.E.Moberg, L.A.Miles,. (2000). Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA 97:2202–7
154. D.Raoult, V.Roux. (1999). The body louse as a vector of reemerging human diseases. Clin Infect Dis 29:888–911
155. S.X.Ren, G.Fu, X.G.Jiang,. (2003). Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 422:888–93
156. D.Richter, D.B.Schlee, R.Allgower, F.R.Matuschka. (2004). Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov., with its hosts in Central Europe. Appl Environ Microbiol 70:6414–19
157. A.Rizzoli, H.Hauffe, G.Carpi,. (2011). Lyme borreliosis in Europe. Euro Surveill 16:1–8
158. S.H.Rooijakkers, J.A.Van Strijp. (2007). Bacterial complement evasion. Mol Immunol 44:23–32
159. E.Rossmann, P.Kraiczy, P.Herzberger,. (2007). Dual binding specificity of a Borrelia hermsii-associated complement regulator-acquiring surface protein for factor H and plasminogen discloses a putative virulence factor of relapsing fever spirochetes. J Immunol 178:7292–301
160. M.L.Sanderson-Smith, Y.Zhang, D.Ly,. (2013). A key role for the urokinase plasminogen activator (uPA) in invasive Group A streptococcal infection. PLoS Pathog 9:e1003469
161. Q.X.Sang. (1998). Complex role of matrix metalloproteinases in angiogenesis. Cell Res 8:171–7
162. D.Sbardella, G.F.Fasciglione, M.Gioia,. (2012). Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. Mol Aspects Med 33:119–208
163. B.Schlott, K.H.Guhrs, M.Hartmann,. (1998). NH2-terminal structural motifs in staphylokinase required for plasminogen activation. J Biol Chem 273:22346–50
164. M.Schneider, M.Nesheim. (2004). A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis. J Biol Chem 279:13333–9
165. F.Schramm, A.Kern, C.Barthel,. (2012). Microarray analyses of inflammation response of human dermal fibroblasts to different strains of Borrelia burgdorferi sensu stricto. PLoS One 7:e40046
166. T.G.Schwan, J.Piesman. (2000). Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice. J Clin Microbiol 38:382–8
167. E.Severi, D.W.Hood, G.H.Thomas. (2007). Sialic acid utilization by bacterial pathogens. Microbiology 153:2817–22
168. T.Seya, S.Nagasawa, M.Matsukura,. (1985). Generation of C3d,g and C3d by urokinase-treated plasma in association with fibrinolysis. Complement 2:165–74
169. C.Siegel, J.Schreiber, K.Haupt,. (2008). Deciphering the ligand-binding sites in the Borrelia burgdorferi complement regulator-acquiring surface protein 2 required for interactions with the human immune regulators factor H and factor H-like protein 1. J Biol Chem 283:34855–63
170. N.Siemens, N.Patenge, J.Otto,. (2011). Streptococcus pyogenes M49 plasminogen/plasmin binding facilitates keratinocyte invasion via integrin-integrin-linked kinase (ILK) pathways and protects from macrophage killing. J Biol Chem 286:21612–22
171. G.H.Siqueira, M.V.Atzingen, I.J.Alves,. (2013). Characterization of three novel adhesins of Leptospira interrogans. Am J Trop Med Hyg 89:1103–16
172. V.Sitprija, V.Pipatanagul, K.Mertowidjojo,. (1980). Pathogenesis of renal disease in leptospirosis: clinical and experimental studies. Kidney Int 17:827–36
173. O.A.Sodeinde, Y.V.Subrahmanyam, K.Stark,. (1992). A surface protease and the invasive character of plague. Science 258:1004–7
174. T.Sorsa, Y.L.Ding, T.Ingman,. (1995). Cellular source, activation and inhibition of dental plaque collagenase. J Clin Periodontol 22:709–17
175. N.M.Souza, M.L.Vieira, I.J.Alves,. (2012). Lsa30, a novel adhesin of Leptospira interrogans binds human plasminogen and the complement regulator C4bp. Microb Pathog 53:125–34
176. G.Stanek, M.Reiter. (2011). The expanding Lyme Borrelia complex–clinical significance of genomic species? Clin Microbiol Infect 17:487–93
177. G.Stanek, G.P.Wormser, J.Gray, F.Strle. (2012). Lyme borreliosis. Lancet 379:461–73
178. D.R.Stanworth, M.W.Turner. (1986). Immunochemical analysis of human and rabbit immunoglobulins and their subunits. In: D.M.Weir, ed. Handbook of experimental immunology. London, UK: Blackwell Scientific, 12.10–12.46
179. A.C.Steere. (1989). Lyme disease. N Engl J Med 321:586–96
180. J.Stie, D.Fox. (2012). Blood-brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin. Microbiology 158:240–58
181. N.Strazielle, J.F.Ghersi-Egea. (2013). Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm 10:1473–91
182. H.Sun. (2006). The interaction between pathogens and the host coagulation system. Physiology (Bethesda) 21:281–8
183. M.Suomalainen, J.Haiko, P.Ramu,. (2007). Using every trick in the book: the Pla surface protease of Yersinia pestis. Adv Exp Med Biol 603:268–78
184. A.Takano, K.Goka, Y.Une,. (2010). Isolation and characterization of a novel Borrelia group of tick-borne borreliae from imported reptiles and their associated ticks. Environ Microbiol 12:134–46
185. A.Toledo, J.L.Coleman, C.J.Kuhlow,. (2012). The enolase of Borrelia burgdorferi is a plasminogen receptor released in outer membrane vesicles. Infect Immun 80:359–68
186. T.Toyokawa, M.Ohnishi, N.Koizumi. (2011). Diagnosis of acute leptospirosis. Expert Rev Anti Infect Ther 9:111–21
187. J.Travis, J.Potempa, H.Maeda. (1995). Are bacterial proteinases pathogenic factors? Trends Microbiol 3:405–7
188. J.Travis, G.S.Salvesen. (1983). Human plasma proteinase inhibitors. Annu Rev Biochem 52:655–709
189. V.J.Uitto, D.Grenier, E.C.Chan, B.C.Mcbride. (1988). Isolation of a chymotrypsinlike enzyme from Treponema denticola. Infect Immun 56:2717–22
190. T.Umemoto, Y.Nakatani, Y.Nakamura, I.Namikawa. (1993). Fibronectin-binding proteins of a human oral spirochete Treponema denticola. Microbiol Immunol 37:75–8
191. M.Van Lookeren Campagne, C.Wiesmann, E.J.Brown. (2007). Macrophage complement receptors and pathogen clearance. Cell Microbiol 9:2095–102
192. A.Verma, C.A.Brissette, A.A.Bowman,. (2010). Leptospiral endostatin-like protein A is a bacterial cell surface receptor for human plasminogen. Infect Immun 78:2053–9
193. A.Verma, J.Hellwage, S.Artiushin,. (2006). LfhA, a novel factor H-binding protein of Leptospira interrogans. Infect Immun 74:2659–66
194. M.L.Vieira, M.P.Alvarez-Flores, K.Kirchgatter,. (2013). Interaction of Leptospira interrogans with human proteolytic systems enhances dissemination through endothelial cells and protease levels. Infect Immun 81:1764–74
195. M.L.Vieira, M.V.Atzingen, R.Oliveira,. (2012). Plasminogen binding proteins and plasmin generation on the surface of Leptospira spp.: the contribution to the bacteria-host interactions. J Biomed Biotechnol 2012:758513
196. M.L.Vieira, M.V.Atzingen, T.R.Oliveira,. (2010). In vitro identification of novel plasminogen-binding receptors of the pathogen Leptospira interrogans. PLoS One 5:e11259
197. M.L.Vieira, Z.M.De Morais, S.A.Vasconcellos,. (2011). In vitro evidence for immune evasion activity by human plasmin associated to pathogenic Leptospira interrogans. Microb Pathog 51:360–5
198. M.L.Vieira, L.G.Fernandes, R.F.Domingos,. (2014). Leptospiral extracellular matrix adhesins as mediators of pathogen-host interactions. FEMS Microbiol Lett 352:129–39
199. M.L.Vieira, S.A.Vasconcellos, A.P.Goncales,. (2009). Plasminogen acquisition and activation at the surface of leptospira species lead to fibronectin degradation. Infect Immun 77:4092–101
200. J.M.Vinetz. (2001). Leptospirosis. Curr Opin Infect Dis 14:527–38
201. J.F.Wagenaar, M.G.Goris, D.L.Partiningrum,. (2010). Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality. Trop Med Int Health 15:152–9
202. B.Wang, J.Sullivan, G.W.Sullivan, G.L.Mandell. (1984). Interaction of leptospires with human polymorphonuclear neutrophils. Infect Immun 44:459–64
203. G.Wang, A.P.Van Dam, I.Schwartz, J.Dankert. (1999). Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 12:633–53
204. D.G.Wolff, M.M.Castiblanco-Valencia, C.M.Abe,. (2013). Interaction of leptospira elongation factor tu with plasminogen and complement factor h: a metabolic leptospiral protein with moonlighting activities. PLoS One 8:e81818
205. M.Yakob, J.H.Meurman, T.Sorsa, B.Soder. (2013). Treponema denticola associates with increased levels of MMP-8 and MMP-9 in gingival crevicular fluid. Oral Dis 19:694–701
206. X.F.Yang, U.Pal, S.M.Alani,. (2004). Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J Exp Med 199:641–8
207. K.C.Young, G.Y.Shi, D.H.Wu,. (1998). Plasminogen activation by streptokinase via a unique mechanism. J Biol Chem 273:3110–16
208. Z.Zhao, H.Chang, R.P.Trevino,. (2003). Selective up-regulation of matrix metalloproteinase-9 expression in human erythema migrans skin lesions of acute lyme disease. J Infect Dis 188:1098–104
209. Z.Zhao, R.Fleming, B.Mccloud, M.S.Klempner. (2007). CD14 mediates cross talk between mononuclear cells and fibroblasts for upregulation of matrix metalloproteinase 9 by Borrelia burgdorferi. Infect Immun 75:3062–9
210. P.F.Zipfel, T.Hallstrom, K.Riesbeck. (2013). Human complement control and complement evasion by pathogenic microbes–tipping the balance. Mol Immunol 56:152–60
211. P.F.Zipfel, M.Mihlan, C.Skerka. (2007a). The alternative pathway of complement: a pattern recognition system. Adv Exp Med Biol 598:80–92
212. P.F.Zipfel, R.Wurzner, C.Skerka. (2007b). Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol Immunol 44:3850–7